Publications by authors named "Carlos E Bueso-Ramos"

100Publications

Thirty-three years later: Two distinct cases of acute lymphoblastic leukemia in one patient.

Am J Hematol 2020 09 8;95(9):1117-1120. Epub 2020 May 8.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
September 2020

Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.

Cytometry B Clin Cytom 2020 Mar 11. Epub 2020 Mar 11.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article and Find Full Text PDF
March 2020

t(11;16)(q23;p13)/KMT2A-CREBBP in hematologic malignancies: presumptive evidence of myelodysplasia or therapy-related neoplasm?

Ann Hematol 2020 Mar 31;99(3):487-500. Epub 2020 Jan 31.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 0072, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
March 2020

Automated Osteosclerosis Grading of Clinical Biopsies Using Infrared Spectroscopic Imaging.

Anal Chem 2020 01 13;92(1):749-757. Epub 2019 Dec 13.

Department of Electrical and Computer Engineering , University of Houston , Houston , Texas 77004 , United States.

View Article and Find Full Text PDF
January 2020

Chronic lymphocytic leukemia with plasmacytic differentiation.

Ann Hematol 2019 Oct 26;98(10):2437-2438. Epub 2019 Aug 26.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
October 2019

Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).

Cancer Genet 2019 10 5;238:18-22. Epub 2019 Jul 5.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, United States.

View Article and Find Full Text PDF
October 2019

Acute myeloid leukemia with t(8;21)(q22;q22.1)/RUNX1-RUNX1T1 and KIT Exon 8 mutation is associated with characteristic mastocytosis and dismal outcomes.

Exp Mol Pathol 2019 06 17;108:131-136. Epub 2019 Apr 17.

Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address:

View Article and Find Full Text PDF
June 2019

Ring sideroblasts in chronic phase of polycythemia vera identifies a subset of patients with an increased risk of progression to blast phase.

Ann Diagn Pathol 2019 Jun 19;40:45-48. Epub 2019 Mar 19.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article and Find Full Text PDF
June 2019

Levels of CD8+ tumor infiltrating lymphocytes correlate with disease burden in bone marrow of therapy Naïve multiple myeloma patients.

Ann Diagn Pathol 2019 Jun 28;40:174-175. Epub 2018 Nov 28.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States of America. Electronic address:

View Article and Find Full Text PDF
June 2019

Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic Leukemia from Primary myelofibrosis with monocytosis.

Hum Pathol 2019 03 15;85:290-298. Epub 2018 Nov 15.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
March 2019

Higher body mass index is associated with better survival in patients with myelodysplastic syndromes.

Leuk Res 2018 08 10;71:63-66. Epub 2018 Jul 10.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States. Electronic address:

View Article and Find Full Text PDF
August 2018

Bone marrow findings in blast phase of polycythemia vera.

Ann Hematol 2018 Mar 28;97(3):425-434. Epub 2017 Dec 28.

Department of Hematopathology, Unit 0072, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
March 2018

Acquired 11q23/ rearrangement of unknown clinical significance.

Int J Clin Exp Pathol 2017 1;10(8):9048-9051. Epub 2017 Aug 1.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center Houston, Texas 77030, USA.

View Article and Find Full Text PDF
August 2017

Feasibility of Lenalidomide Therapy for Persistent Chronic Lymphocytic Leukemia after Allogeneic Transplantation.

Biol Blood Marrow Transplant 2017 Aug 8;23(8):1405-1410. Epub 2017 May 8.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article and Find Full Text PDF
August 2017

Characteristics and clinical implications of reactive germinal centers in the bone marrow.

Hum Pathol 2017 10 17;68:7-21. Epub 2017 Apr 17.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
October 2017

Quality and cost comparison of powered versus manual bone marrow biopsy devices in patients with myelofibrosis.

Leuk Lymphoma 2017 10 28;58(10):2508-2510. Epub 2017 Feb 28.

f Department of Hematopathology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article and Find Full Text PDF
October 2017

Primary autoimmune myelofibrosis: a case report and review of the literature.

Int J Hematol 2017 Apr 9;105(4):536-539. Epub 2016 Nov 9.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

View Article and Find Full Text PDF
April 2017

Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.

Am J Surg Pathol 2017 01;41(1):82-93

*Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston ‡Department of Pathology, UT Southwestern Medical Center, Dallas, TX †Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY.

View Article and Find Full Text PDF
January 2017

Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report.

Medicine (Baltimore) 2016 Oct;95(41):e4934

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX Department of Pathology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
October 2016

High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome.

Clin Lymphoma Myeloma Leuk 2016 08 1;16 Suppl:S30-8. Epub 2016 Apr 1.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
August 2016

Advances in B-lymphoblastic leukemia: cytogenetic and genomic lesions.

Ann Diagn Pathol 2016 Aug 9;23:43-50. Epub 2016 Apr 9.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
August 2016

Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review.

Mol Cytogenet 2016 27;9:23. Epub 2016 Feb 27.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 USA.

View Article and Find Full Text PDF
February 2016

Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.

Am J Surg Pathol 2016 May;40(5):676-88

Departments of *Hematopathology †Stem Cell Transplantation §Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX #Biostatistics **Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston ¶Department of Pathology, UT Southwestern Medical Center, Dallas, TX ‡Department of Pathology and Cell Biology, Columbia University Medical Center, New York, NY ∥Department of Pathology, University of Miami, Miami, FL.

View Article and Find Full Text PDF
May 2016

Acute promyelocytic leukemia presented as a relapse of acute myeloid leukemia.

Am J Hematol 2016 Jun 29;91(4):E274-6. Epub 2016 Feb 29.

Department of Leukemia, the University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
June 2016

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

J Natl Cancer Inst 2015 Nov 13;108(2). Epub 2015 Nov 13.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA (JY, JJ, NJMR, MC, JPJI); Department of Leukemia (JY, RT, JJ, NJMR, SAP, SMK, FR, HMK, JPJI) and Department of Hematopathology (CEBR), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
November 2015

MYC/BCL6 double-hit lymphoma (DHL): a tumour associated with an aggressive clinical course and poor prognosis.

Histopathology 2016 Jun 8;68(7):1090-8. Epub 2015 Dec 8.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF
June 2016

Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1.

Am J Clin Pathol 2015 Sep;144(3):377-92

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston; and

View Article and Find Full Text PDF
September 2015

Therapy-Related Myeloid Neoplasms.

Am J Clin Pathol 2015 Aug;144(2):207-18

The Division of Hematopathology, Mayo Clinic, Rochester, MN.

View Article and Find Full Text PDF
August 2015

Introduction to the 2013 Workshop of the Society for Hematopathology/European Association for Haematopathology.

Am J Clin Pathol 2015 Jul;144(1):4-5

Division of Hematopathology, Department of Pathology and Laboratory Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida.

View Article and Find Full Text PDF
July 2015

Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia.

J Natl Compr Canc Netw 2015 Jan;13(1):19-22

From the Departments of Hematopathology, Leukemia, Genomic Medicine, and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF
January 2015

Isolated +15 in bone marrow: disease-associated or a benign finding?

Leuk Res 2015 Jan 15;39(1):72-6. Epub 2014 Nov 15.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article and Find Full Text PDF
January 2015

Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma.

Ann Diagn Pathol 2014 Aug 13;18(4):203-9. Epub 2014 Apr 13.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article and Find Full Text PDF
August 2014

Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: a diagnostic dilemma?

Clin Lymphoma Myeloma Leuk 2014 Jun 2;14(3):e95-e100. Epub 2014 Jan 2.

Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article and Find Full Text PDF
June 2014

Immunostaining for rapid diagnosis of acute promyelocytic leukemia with the tetramethylrhodamine-5-isothiocyanate-conjugated anti-promyelocytic leukemia monoclonal antibody PG-M3.

Arch Pathol Lab Med 2013 Nov;137(11):1669-73

From the Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston (Drs Alayed, Medeiros, Konoplev, and Bueso-Ramos, Mr Phan, Ms Ojiaku, Ms Patel, Ms McCord, Mr Yap, and Ms Woods); and the Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia (Dr Alayed).

View Article and Find Full Text PDF
November 2013

MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.

Elife 2013 Jul 16;2:e00825. Epub 2013 Jul 16.

Institute of Transfusion Medicine , University Hospital Essen , Essen , Germany ; Department of Pediatric Oncology , Dana-Farber Cancer Institute , Boston , United States.

View Article and Find Full Text PDF
July 2013